Free tool
Oncology stocks
We cover 90 companies grouped under the Oncology theme. The median market value in the group is $21.41M. Across the group, the median move over the past trading day is −0.87%. 34% of the 90 with a 200-day average trade above it. Price change over the past year runs from −90.2% to +51.2% across the middle 80 percent of the group, with a median of −44.4%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
90 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +5.09% |
| BMY | Bristol-Myers Squibb Company | $138.03B | Large cap | +47.01% |
| RVMD | Revolution Medicines, Inc. | $46.18B | Large cap | +466.35% |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +25.21% |
| BNTX | BioNTech SE | $28.28B | Large cap | +9.27% |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% |
| GMAB | Genmab A/S | $21.42B | Large cap | +36.20% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% |
| SMMT | Summit Therapeutics Inc. | $11.35B | Large cap | −42.63% |
| ACRV | Acrivon Therapeutics, Inc. | $93.42M | Micro cap | +52.94% |
| MAIA | MAIA Biotechnology, Inc. | $84.56M | Micro cap | −15.76% |
| VRCA | Verrica Pharmaceuticals Inc. | $84.35M | Micro cap | −13.25% |
| CTOR | Citius Oncology, Inc. | $83.24M | Micro cap | −62.34% |
| ELTX | Elicio Therapeutics, Inc. | $78.32M | Micro cap | −71.29% |
| APLM | Apollomics, Inc. | $76.75M | Micro cap | +320.55% |
| OSTX | OS Therapies Incorporated | $76.68M | Micro cap | −34.00% |
| CRDF | Cardiff Oncology, Inc. | $76.56M | Micro cap | −54.65% |
| PLRX | Pliant Therapeutics, Inc. | $73.69M | Micro cap | −31.36% |
| XBIT | XBiotech Inc. | $70.43M | Micro cap | −33.62% |
| PMVP | PMV Pharmaceuticals, Inc. | $70.03M | Micro cap | −7.75% |
| RNXT | RenovoRx, Inc. | $67.24M | Micro cap | +61.08% |
| BOLD | Boundless Bio, Inc. | $66.31M | Micro cap | +155.70% |
| XLO | Xilio Therapeutics, Inc. | $59.55M | Micro cap | −5.63% |
| HRTX | Heron Therapeutics, Inc. | $59.27M | Micro cap | −77.04% |
| IMMP | Immutep Limited | $56.00M | Micro cap | −77.11% |
| TIL | Instil Bio, Inc. | $53.10M | Micro cap | −72.04% |
| IBO | Impact BioMedical Inc. | $49.62M | Micro cap | −24.12% |
| HOWL | Werewolf Therapeutics, Inc. | $48.05M | Micro cap | −25.65% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $44.46M | Micro cap | −74.90% |
| CNTX | Context Therapeutics Inc. | $40.00M | Micro cap | −50.73% |
| BCTX | BriaCell Therapeutics Corp. | $35.06M | Micro cap | −46.97% |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% |
| ATNM | Actinium Pharmaceuticals, Inc. | $31.69M | Micro cap | −42.61% |
| BYSI | BeyondSpring Inc. | $28.37M | Micro cap | −62.09% |
| CVM | CEL-SCI Corporation | $28.32M | Micro cap | −87.65% |
| LTRN | Lantern Pharma Inc. | $27.87M | Micro cap | −46.17% |
| NXTC | NextCure, Inc. | $27.05M | Micro cap | +11.37% |
| EVAX | Evaxion A/S | $27.02M | Micro cap | +6.93% |
| PSTV | Plus Therapeutics Inc | $26.64M | Micro cap | −68.67% |
| ATOS | Atossa Therapeutics, Inc. | $26.45M | Micro cap | −76.75% |
| MRKR | Marker Therapeutics, Inc. | $24.18M | Micro cap | +54.26% |
| CLRB | Cellectar Biosciences, Inc. | $24.01M | Micro cap | −47.30% |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% |
| CCM | Concord Medical Services Holdings Limited | $21.49M | Micro cap | −10.47% |
| ALLR | Allarity Therapeutics, Inc. | $21.32M | Micro cap | −15.72% |
| ABVC | ABVC BioPharma, Inc. | $18.95M | Micro cap | −76.14% |
| RADX | Radiopharm Theranostics Limited | $18.29M | Micro cap | −58.87% |
| TPST | Tempest Therapeutics, Inc. | $17.86M | Micro cap | −89.96% |
| AKTX | Akari Therapeutics, Plc | $17.72M | Micro cap | −72.42% |
| MDCX | Medicus Pharma Ltd. | $16.96M | Micro cap | −86.77% |
| CTXR | Citius Pharmaceuticals, Inc. | $16.57M | Micro cap | −57.88% |
| LSTA | Lisata Therapeutics, Inc. | $15.68M | Micro cap | −30.40% |
| INTS | Intensity Therapeutics, Inc. | $14.79M | Micro cap | −40.00% |
| PHIO | Phio Pharmaceuticals Corp. | $13.94M | Micro cap | −40.89% |
| GTBP | GT Biopharma, Inc. | $13.52M | Micro cap | −74.55% |
| PDSB | PDS Biotechnology Corporation | $12.49M | Micro cap | −82.56% |
| APRE | Aprea Therapeutics, Inc. | $12.34M | Micro cap | −38.75% |
| BLRX | BioLineRx Ltd. | $11.79M | Micro cap | −26.63% |
| MBRX | Moleculin Biotech, Inc. | $11.69M | Micro cap | −96.05% |
| TOVX | Theriva Biologics, Inc. | $11.16M | Micro cap | −42.10% |
| LNAI | Lunai Bioworks Inc. | $9.97M | Micro cap | −89.34% |
| IMNN | Imunon, Inc. | $9.15M | Micro cap | −73.10% |
| XBIO | Xenetic Biosciences, Inc. | $9.04M | Micro cap | +35.92% |
| CNSP | CNS Pharmaceuticals, Inc. | $8.48M | Micro cap | −13.51% |
| AIM | AIM ImmunoTech Inc. | $7.61M | Micro cap | −89.69% |
| BOLT | Bolt Biotherapeutics, Inc. | $7.55M | Micro cap | −26.73% |
| CURX | Curanex Pharmaceuticals Inc | $7.21M | Micro cap | −1.29% |
| CANF | Can-Fite BioPharma Ltd. | $7.11M | Micro cap | −74.85% |
| ITOC | iTonic Holdings Ltd. | $6.75M | Micro cap | −59.75% |
| NCNA | NuCana plc | $6.37M | Micro cap | −52.78% |
| LIMN | Liminatus Pharma, Inc. | $6.19M | Micro cap | +46.03% |
| PCSA | Processa Pharmaceuticals, Inc. | $5.95M | Micro cap | −60.00% |
| KAPA | Kairos Pharma, Ltd. | $5.88M | Micro cap | −77.97% |
| BCAB | BioAtla, Inc. | $5.20M | Micro cap | −86.04% |
| HCWB | HCW Biologics Inc. | $4.96M | Micro cap | −55.15% |
| APVO | Aptevo Therapeutics Inc. | $4.34M | Micro cap | −92.52% |
| OSRH | OSR Health, Inc. | $4.09M | Micro cap | −80.93% |
| CRIS | Curis, Inc. | $3.86M | Micro cap | −5.52% |
| RDHL | RedHill Biopharma Ltd. | $3.74M | Micro cap | −53.74% |
| CLDI | Calidi Biotherapeutics, Inc. | $3.49M | Micro cap | −19.16% |
| GOVX | GeoVax Labs, Inc. | $3.34M | Micro cap | −96.67% |
| ARTL | Artelo Biosciences, Inc. | $3.27M | Micro cap | −97.37% |
| PPBT | Purple Biotech Ltd | $2.81M | Micro cap | −92.21% |
| RNAZ | TransCode Therapeutics, Inc. | $2.48M | Micro cap | −76.72% |
| PPCB | Propanc Biopharma, Inc. | $2.44M | Micro cap | −98.54% |
| SLXN | Silexion Therapeutics Corp | $1.97M | Micro cap | −95.11% |
| DCOY | Decoy Therapeutics Inc. | $1.95M | Micro cap | −95.78% |
| BDRX | Biodexa Pharmaceuticals Plc | $1.07M | Micro cap | −96.58% |
| APM | Aptorum Group Ltd | $570.06K | Micro cap | +273.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.